Pfizer Wins Corporate Citizenship Award For Global Health Partnerships Program

PfizerPfizer Inc. has received the 2011 Business Civic Leadership Center's Corporate Citizenship Award in the Best International Ambassador category for Pfizer's Global Health Partnerships program. The "Citizens" Awards honor excellence in corporate citizenship and civic leadership for initiatives in both the United States and across the world.

"The essence of a successful corporate social responsibility program is when it becomes a model that other companies want to imitate," said U.S. Chamber of Commerce Business Civic Leadership Center Founder and Executive Director Stephen Jordan. "This award for Pfizer’s Global Health Partnership validates what many companies have known for a long time. This is a great program."

Pfizer's Global Health Partnerships (GHP) combines the philanthropic and in-kind resources of the Pfizer Foundation and Pfizer Inc. to combat noncommunicable diseases (NCDs) by strengthening healthcare systems and infrastructure to support cancer and tobacco control efforts. The fight against NCDs and their risk factors, such as tobacco use, has largely been neglected in overseas development aid to low and middle income countries. Only 2% of the more than $44 billion in aid has been devoted to fighting these diseases in the developing world. Pfizer and the Pfizer Foundation recognize this gap and through GHP have invested $47 million over four years in promising cancer and tobacco-control partner organizations operating in 46 countries.

"Through Pfizer's Global Health Partnerships, Pfizer supports the growth of promising cancer- and tobacco-control organizations united by the shared mission of accelerating the pace of progress in the fight against cancer," said Caroline Roan, vice president, Corporate Responsibility and president of the Pfizer Foundation. "Pfizer is proud to be awarded Best International Ambassador Award and for its commitment to foster a culture of results-oriented discovery and innovation."

The 2011 Business Civic Leadership Awards was presented on Thursday, November 17th, at the Corporate Citizenship Awards gala in Washington, DC.

About the Business Civic Leadership Center (BCLC)
BCLC is the U.S. Chamber's resource and voice for businesses' social and philanthropic interests. Its mission is to advance the positive role of business in society. The U.S. Chamber of Commerce is the world’s largest business federation representing the interests of more than 3 million businesses of all sizes, sectors, and regions, as well as state and local chambers and industry associations.

Pfizer Inc.: Working together for a healthier world™
At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world's best-known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world's leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.

Most Popular Now

Fasenra (benralizumab) receives US FDA approval fo…

AstraZeneca and its global biologics research and development arm, MedImmune, announced that the US Food and Drug Administration (FDA) has approved Fasenra (benralizumab)...

Alzheimer's disease might be a 'whole body' proble…

Alzheimer's disease, the leading cause of dementia, has long been assumed to originate in the brain. But research from the University of British Columbia and Chinese scie...

Cancer cells destroyed with dinosaur extinction me…

Cancer cells can be targeted and destroyed with the metal from the asteroid that caused the extinction of the dinosaurs, according to new research by an international col...

Novartis confirms leadership in multiple sclerosis…

Novartis today announced it will present 54 scientific abstracts from across its multiple sclerosis (MS) research portfolio at the 7th Joint European and Americas Committ...

Amgen and Novartis announce expanded collaboration…

Amgen (NASDAQ:AMGN) and Novartis announced an expanded collaboration with the Banner Alzheimer's Institute (BAI) to initiate a new trial - the Alzheimer's Prevention Init...

Transplanted hematopoietic stem cells reverse dama…

Researchers at University of California San Diego School of Medicine report that a single infusion of wildtype hematopoietic stem and progenitor cells (HSPCs) into a mous...

Novartis announces the planned acquisition of Adva…

Novartis announced today, that it has entered a memorandum of understanding with Advanced Accelerator Applications (AAA) under which Novartis intends to commence a tender...

'Precision Medicine' may not always be so precise

Precision Medicine in oncology, where genetic testing is used to determine the best drugs to treat cancer patients, is not always so precise when applied to some of the w...

China's out of control 'silent killer' affects one…

More than one-third of adults in China have high blood pressure - often dubbed the "silent killer" for its lack of symptoms - but only about one in 20 have the condition ...

New tissue-engineered blood vessel replacements on…

Researchers at the University of Minnesota have created a new lab-grown blood vessel replacement that is composed completely of biological materials, but surprisingly doe...

New US study reveals key reasons why millions of p…

Few of the more than 90 million Americans(1) with obesity are seeking and receiving long-term obesity care, according to new data from the Awareness, Care and Treatment I...

Efficacy and safety maintained in patients who swi…

Boehringer Ingelheim today announced one-year data from VOLTAIRE®-RA, a pivotal Phase III clinical trial comparing Cyltezo® (adalimumab-adbm) and reference product Humira...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]